NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 1.010
-0.002 (-0.20%)
Jul 24, 2026, 4:58 PM CET
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of 127.66 million as of July 24, 2026. Its market cap has decreased by -0.17% in one year.
Market Cap
127.66M
Enterprise Value
95.33M
Revenue
9.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.01
ChartMarket Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 33.03M to 127.66M, an increase of 286.53%. That is a compound annual growth rate of 16.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 127.66M | 56.77% |
| Dec 30, 2025 | 81.43M | -60.77% |
| Dec 30, 2024 | 207.58M | 129.58% |
| Dec 29, 2023 | 90.42M | -62.64% |
| Dec 30, 2022 | 242.03M | -9.28% |
| Dec 30, 2021 | 266.79M | -35.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 175.18M |
| Simris Group AB (PUBL) | 161.98M |
| Diamyd Medical AB | 161.18M |
| Xintela AB | 160.20M |
| Initiator Pharma | 159.50M |
| Nanologica AB | 144.66M |
| Active Biotech AB | 139.18M |
| Biovica International AB | 131.36M |